SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-125363
Filing Date
2024-04-30
Accepted
2024-04-30 17:21:51
Documents
6
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 PRE 14A d814423dpre14a.htm PRE 14A 668932
2 GRAPHIC g814423g0423115746058.jpg GRAPHIC 4429
3 GRAPHIC g814423g0423115746391.jpg GRAPHIC 17026
4 GRAPHIC g814423g0423160242927.jpg GRAPHIC 16317
5 GRAPHIC g814423g25d26.jpg GRAPHIC 354835
6 GRAPHIC g814423g26d27.jpg GRAPHIC 331063
  Complete submission text file 0001193125-24-125363.txt   1667765
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32001 | Film No.: 24898659
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)